The JSE had its third day of gains on Tuesday as progress in creating a Covid-19 vaccine and the EU’s stimulus deal boosted appetite for riskier assets.
Markets rallied following reports that an experimental vaccine trial by Oxford University and British-Swedish pharmaceutical group AstraZeneca induced an immune response. Data showed that a vaccine trial by German BioNTech and US pharmaceutical firm Pfizer also showed positive results and that it is safe for humans.
Italia Ultime Notizie, Italia Notizie
Similar News:Puoi anche leggere notizie simili a questa che abbiamo raccolto da altre fonti di notizie.
MARKET WRAP: JSE firms on ongoing stimulus talks‘The dollar was firmer against most currencies today with the exception of the euro as markets await the outcome of EU stimulus talks’
Leggi di più »
Euro hovers near 4-month peak as market looks to EU summitThe euro hovered near four-month highs against the dollar as investors held on to hopes that European leaders would hammer out an economic rescue deal.
Leggi di più »
Market rebound helps lift Ninety One and CoronationNinety One assets under management rose to £118bn during the prior quarter, while Coronation's increased to R570bn
Leggi di più »
WATCH: How lockdown has laid waste to the labour marketPrincipal investigator of the NIDS CRAM project Nic Spaull talks to Business Day TV about what their survey revealed.
Leggi di più »
Market rebound helps lift Ninety One and CoronationNinety One assets under management rose to £118bn during the prior quarter, while Coronation's increased to R570bn
Leggi di più »